New insights into intracellular locations and functions of heme oxygenase-1

Antioxidants and Redox Signaling

Volumn 20, Issue 11, 2014, Pages 1723-1742

  Dunn, Louise L ^a,b   Midwinter, Robyn G ^c   Ni, Jun ^a,b   Hamid, Hafizah A ^a,b   Parish, Christopher R ^d   Stocker, Roland ^a,b  

^a VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d Australian National University   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; BILIRUBIN; BILIVERDIN; CARBON MONOXIDE; FENOFIBRATE; FLUINDOSTATIN; HEME ARGINATE; HEME OXYGENASE 1; HEMIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PACLITAXEL; PRAVASTATIN; PROBUCOL; RAPAMYCIN; ROSIGLITAZONE; SIMVASTATIN; SUCCINOBUCOL;

ACETYLATION; CARDIOVASCULAR DISEASE; CATABOLISM; CAVEOLA; CELL FUNCTION; CELL MIGRATION; CELL NUCLEUS; CELL TYPE; CELLULAR DISTRIBUTION; DIABETES MELLITUS; DIMERIZATION; ENDOPLASMIC RETICULUM; HUMAN; INTRACELLULAR SPACE; METABOLIC DISORDER; MITOCHONDRION; NEOPLASM; NONHUMAN; OLIGOMERIZATION; PALMITOYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW; STRESS; UBIQUITINATION;

AMINO ACID SEQUENCE; ANIMALS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; HEME OXYGENASE-1; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT;

EID: 84896322002     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5675     Document Type: Review

References (200)

1. Adin CA, Croker BP, and Agarwal A. Protective effects of exogenous bilirubin on ischemia-reperfusion injury in the isolated, perfused rat kidney. Am J Physiol Renal Physiol 288: F778-F784, 2005.
2. Aicher A, Zeiher AM, and Dimmeler S. Mobilizing endothelial progenitor cells. Hypertension 45: 321-325, 2005.
3. Ali F, Hamdulay SS, Kinderlerer AR, Boyle JJ, Lidington EA, Yamaguchi T, Soares MP, Haskard DO, Randi AM, and Mason JC. Statin-mediated cytoprotection of human vascular endothelial cells: a role for Kruppel-like factor 2-dependent induction of heme oxygenase-1. J Thromb Hae-most 5: 2537-2546, 2007.
4. Araujo JA, Meng L, Tward AD, Hancock WW, Zhai Y, Lee A, Ishikawa K, Iyer S, Buelow R, Busuttil RW, Shih DM, Lusis AJ, and Kupiec-Weglinski JW. Systemic rather than local heme oxygenase-1 overexpression improves cardiac allograft outcomes in a new transgenic mouse. J Immunol 171: 1572-1580, 2003.
5. Arredondo M, Jorquera D, Carrasco E, Albala C, and Hertrampf E. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with iron status in persons with type 2 diabetes mellitus. Am J Clin Nutr 86: 1347-1353, 2007.
6. Bao W, Song F, Li X, Rong S, Yang W, Wang D, Xu J, Fu J, Zhao Y, and Liu L. Association between heme oxygenase-1 gene promoter polymorphisms and type 2 diabetes melli-tus: a HuGE review and meta-analysis. Am J Epidemiol 172: 631-636, 2010.
7. Baranano DE, Rao M, Ferris CD, and Snyder SH. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA 99: 16093-16098, 2002.
8. Barone E, Di Domenico F, Sultana R, Coccia R, Mancuso C, Perluigi M, and Butterfield DA. Heme oxygenase-1 post-translational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment. Free Radic Biol Med 52: 2292-2301, 2012.
9. Beck K, Wu BJ, Ni J, Santiago FS, Malabanan KP, Li C, Wang Y, Khachigian LM, and Stocker R. Interplay between heme oxygenase-1 and the multifunctional transcription factor yin yang 1 in the inhibition of intimal hyperplasia. Circ Res 107: 1490-1497, 2010.
10. Bindu S, Pal C, Dey S, Goyal M, Alam A, Iqbal MS, Dutta S, Sarkar S, Kumar R, Maity P, and Bandyopadhyay U. Translocation of heme oxygenase-1 to mitochondria is a novel cytoprotective mechanism against non-steroidal anti-inflammatory drug-induced mitochondrial oxidative stress, apoptosis, and gastric mucosal injury. J Biol Chem 286: 39387-39402, 2011.
11. Blancou P and Anegon I. Editorial: heme oxygenase-1 and dendritic cells: what else? J Leukoc Biol 87: 185-187, 2010.
12. Bouche D, Chauveau C, Roussel JC, Mathieu P, Braudeau C, Tesson L, Soulillou JP, Iyer S, Buelow R, and Anegon I. Inhibition of graft arteriosclerosis development in rat aortas following heme oxygenase-1 gene transfer. Transpl Immunol 9: 235-238, 2002.
13. Braudeau C, Bouchet D, Tesson L, Iyer S, Remy S, Buelow R, Anegon I, and Chauveau C. Induction of long-term cardiac allograft survival by heme oxygenase-1 gene transfer. Gene Ther 11: 701-710, 2004.
14. Brouard S, Otterbein LE, Anrather J, Tobiasch E, Bach FH, Choi AM, and Soares MP. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 192: 1015-1026, 2000.
15. Burgess A, Li M, Vanella L, Kim DH, Rezzani R, Rodella L, Sodhi K, Canestraro M, Martasek P, Peterson SJ, Kappas A, and Abraham NG. Adipocyte heme oxygenase-1 induction attenuates metabolic syndrome in both male and female obese mice. Hypertension 56: 1124-1130, 2010.
16. Chen HH, Chen TW, and Lin H. Pravastatin attenuates carboplatin-induced nephrotoxicity in rodents via peroxi-some proliferator-activated receptor alpha-regulated heme oxygenase-1. Mol Pharmacol 78: 36-45, 2010.
17. Chen JC, Huang KC, and Lin WW. HMG-CoA reductase inhibitors upregulate heme oxygenase-1 expression in murine RAW264.7 macrophages via ERK, p38 MAPK and protein kinase G pathways. Cell Signal 18: 32-39, 2006.
18. Chen YH, Lin SJ, Lin MW, Tsai HL, Kuo SS, Chen JW, Charng MJ, Wu TC, Chen LC, Ding YA, Pan WH, Jou YS, and Chau LY. Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Hum Genet 111: 1-8, 2002.
19. Chen-Roetling J, Li Z, Chen M, Awe OO, and Regan RF. Heme oxygenase activity and hemoglobin neurotoxicity are attenuated by inhibitors of the MEK/ERK pathway. Neu-ropharmacology 56: 922-928, 2009.
20. Cheng C, Noordeloos AM, Jeney V, Soares MP, Moll F, Pasterkamp G, Serruys PW, and Duckers HJ. Heme oxygenase 1 determines atherosclerotic lesion progression into a vulnerable plaque. Circulation 119: 3017-3027, 2009.
21. Cheriyath P, Gorrepati VS, Peters I, Nookala V, Murphy ME, Srouji N, and Fischman D. High total bilirubin as a protective factor for diabetes mellitus: an analysis of NHANES data from 1999-2006. J Clin Med Res 2: 201-206, 2010.
22. Choi BM, Kim YM, Jeong YR, Pae HO, Song CE, Park JE, Ahn YK, and Chung HT. Induction of heme oxygenase-1 is involved in anti-proliferative effects of paclitaxel on rat vascular smooth muscle cells. Biochem Biophys Res Commun 321: 132-137, 2004.
23. Choi SW, Yeung VT, and Benzie IF. Heme oxygenase mi-crosatellite polymorphism, oxidative stress, glycemic control, and complication development in type 2 diabetes patients. Free Radic Biol Med 53: 60-63, 2012.
24. Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, Olsen JV, and Mann M. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325: 834-840, 2009.
25. Christou H, Morita T, Hsieh CM, Koike H, Arkonac B, Perrella MA, and Kourembanas S. Prevention of hypoxia-induced pulmonary hypertension by enhancement of endogenous heme oxygenase-1 in the rat. Circ Res 86: 1224-1229, 2000.
26. Clark JE, Foresti R, Green CJ, and Motterlini R. Dynamics of haem oxygenase-1 expression and bilirubin production in cellular protection against oxidative stress. Biochem J 348: 615-619, 2000.
27. Collinson EJ, Wimmer-Kleikamp S, Gerega SK, Yang YH, Parish CR, Dawes IW, and Stocker R. The yeast homolog of heme oxygenase-1 affords cellular antioxidant protection via the transcriptional regulation of known antioxidant genes. J Biol Chem 286: 2205-2214, 2011.
28. Converso DP, Taille C, Carreras MC, Jaitovich A, Poderoso JJ, and Boczkowski J. HO-1 is located in liver mitochondria and modulates mitochondrial heme content and metabolism. FASEB J 20: 1236-1238, 2006.
29. Cruse I and Maines MM. Evidence suggesting that the two forms of heme oxygenase are products of different genes. J Biol Chem 263: 3348-3353, 1988.
30. Cudmore M, Ahmad S, Al-Ani B, Fujisawa T, Coxall H, Chudasama K, Devey LR, Wigmore SJ, Abbas A, Hewett PW, and Ahmed A. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation 115: 1789-1797, 2007.
31. Datla SR, Dusting GJ, Mori TA, Taylor CJ, Croft KD, and Jiang F. Induction of heme oxygenase-1 in vivo suppresses NADPH oxidase derived oxidative stress. Hypertension 50: 636-642, 2007.
32. Deininger MH, Meyermann R, Trautmann K, Duffner F, Grote EH, Wickboldt J, and Schluesener HJ. Heme oxyge-nase (HO)-1 expressing macrophages/microglial cells accumulate during oligodendroglioma progression. Brain Res 882: 1-8, 2000.
33. Delaby C, Pilard N, Puy H, and Canonne-Hergaux F. Sequential regulation of ferroportin expression after ery-throphagocytosis in murine macrophages: early mRNA induction by haem, followed by iron-dependent protein expression. Biochem J 411: 123-131, 2008.
34. Delaby C, Rondeau C, Pouzet C, Willemetz A, Pilard N, Desjardins M, and Canonne-Hergaux F. Subcellular localization of iron and heme metabolism related proteins at early stages of erythrophagocytosis. PLoS One 7: e42199, 2012.
35. Deng YM, Wu BJ, Witting PK, and Stocker R. Probucol protects against smooth muscle cell proliferation by upregulat-ing heme oxygenase-1. Circulation 110: 1855-1860, 2004.
36. Deramaudt BM, Braunstein S, Remy P, and Abraham NG. Gene transfer of human heme oxygenase into coronary endothelial cells potentially promotes angiogenesis. J Cell Biochem 68: 121-127, 1998.
37. Deshane J, Chen S, Caballero S, Grochot-Przeczek A, Was H, Li Calzi S, Lach R, Hock TD, Chen B, Hill-Kapturczak N, Siegal GP, Dulak J, Jozkowicz A, Grant MB, and Agarwal A. Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism. J Exp Med 204: 605-618, 2007.
38. Dick P, Schillinger M, Minar E, Mlekusch W, Amighi J, Sabeti S, Schlager O, Raith M, Endler G, Mannhalter C, Wagner O, and Exner M. Haem oxygenase-1 genotype and cardiovascular adverse events in patients with peripheral artery disease. Eur J Clin Invest 35: 731-737, 2005.
39. Dowal L, Yang W, Freeman MR, Steen H, and Flaumenhaft R. Proteomic analysis of palmitoylated platelet proteins. Blood 118: e62-e73, 2011.
40. Du D, Chang S, Chen B, Zhou H, and Chen ZK. Adeno-virus-mediated heme oxygenase transfer inhibits graft arteriosclerosis in rat aortic transplants. Transplant Proc 39: 3446-3448, 2007.
41. Dubuis E, Potier M, Wang R, and Vandier C. Continuous inhalation of carbon monoxide attenuates hypoxic pulmonary hypertension development presumably through activation of BKCa channels. Cardiovasc Res 65: 751-761, 2005.
42. Duckers HJ, Boehm M, True AL, Yet SF, San H, Park JL, Clinton Webb R, Lee ME, Nabel GJ, and Nabel EG. Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med 7: 693-698, 2001.
43. Eisenstein RS, Garcia-Mayol D, Pettingell W, and Munro HN. Regulation of ferritin and heme oxygenase synthesis in rat fibroblasts by different forms of iron. Proc Natl Acad Sci USA 88: 688-692, 1991.
44. Endler G, Exner M, Schillinger M, Marculescu R, Sunder-Plassmann R, Raith M, Jordanova N, Wojta J, Mannhalter C, Wagner OF, and Huber K. A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with increased bilirubin and HDL levels but not with coronary artery disease. Thromb Haemost 91: 155-161, 2004.
45. Erdogan D, Gullu H, Yildirim E, Tok D, Kirbas I, Ciftci O, Baycan ST, and Muderrisoglu H. Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women. Atherosclerosis 184: 431-437, 2006.
46. Exner M, Schillinger M, Minar E, Mlekusch W, Schlerka G, Haumer M, Mannhalter C, and Wagner O. Heme oxyge-nase-1 gene promoter microsatellite polymorphism is associated with restenosis after percutaneous transluminal angioplasty. J Endovasc Ther 8: 433-440, 2001.
47. Farhangkhoee H, Khan ZA, Mukherjee S, Cukiernik M, Barbin YP, Karmazyn M, and Chakrabarti S. Heme oxy-genase in diabetes-induced oxidative stress in the heart. J Mol Cell Cardiol 35: 1439-1448, 2003.
48. Feron O, Saldana F, Michel JB, and Michel T. The endo-thelial nitric-oxide synthase-caveolin regulatory cycle. J Biol Chem 273: 3125-3128, 1998.
49. Finn AV, John M, Nakazawa G, Polavarapu R, Karmali V, Xu X, Cheng Q, Davis T, Raghunathan C, Acampado E, Ezell T, Lajoie S, Eppihimer M, Kolodgie FD, Virmani R, and Gold HK. Differential healing after sirolimus, pacli-taxel, and bare metal stent placement in combination with peroxisome proliferator-activator receptor gamma agonists: requirement for mTOR/Akt2 in PPARgamma activation. Circ Res 105: 1003-1012, 2009.
50. Fujita T, Toda K, Karimova A, Yan SF, Naka Y, Yet SF, and Pinsky DJ. Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibri-nolysis. Nat Med 7: 598-604, 2001.
51. Gandini NA, Fermento ME, Salomon DG, Blasco J, Patel V, Gutkind JS, Molinolo AA, Facchinetti MM, and Curino AC. Nuclear localization of heme oxygenase-1 is associated with tumor progression of head and neck squamous cell carcinomas. Exp Mol Pathol 93: 237-245, 2012.
52. Ghoreschi K, Bruck J, Kellerer C, Deng C, Peng H, Rothfuss O, Hussain RZ, Gocke AR, Respa A, Glocova I, Valtcheva N, Alexander E, Feil S, Feil R, Schulze-Osthoff K, Rupec RA, Lovett-Racke AE, Dringen R, Racke MK, and Rocken M. Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells. J Exp Med 208: 2291-2303, 2011.
53. Giordano A, Nisoli E, Tonello C, Cancello R, Carruba MO, and Cinti S. Expression and distribution of heme oxygenase-1 and-2 in rat brown adipose tissue: the modulatory role of the noradrenergic system. FEBS Lett 487: 171-175, 2000.
54. Giorgi C, De Stefani D, Bononi A, Rizzuto R, and Pinton P. Structural and functional link between the mitochondrial network and the endoplasmic reticulum. Int J Biochem Cell Biol 41: 1817-1827, 2009.
55. Gloria MA, Cenedeze MA, Pacheco-Silva A, and Camara NO. The blockade of cyclooxygenases-1 and-2 reduces the effects of hypoxia on endothelial cells. Braz J Med Biol Res 39: 1189-1196, 2006.
56. Gottlieb Y, Truman M, Cohen LA, Leichtmann-Bardoogo Y, and Meyron-Holtz EG. Endoplasmic reticulum anchored heme-oxygenase-1 faces the cytosol. Haematologica 97: 1489-1493, 2012.
57. Grochot-Przeczek A, Lach R, Mis J, Skrzypek K, Gozdecka M, Sroczynska P, Dubiel M, Rutkowski A, Kozakowska M, Zagorska A, Walczynski J, Was H, Kotlinowski J, Drukala J, Kurowski K, Kieda C, Herault Y, Dulak J, and Jozkowicz A. Heme oxygenase-1 accelerates cutaneous wound healing in mice. PLoS One 4: e5803, 2009.
58. Grosser N, Abate A, Oberle S, Vreman HJ, Dennery PA, Becker JC, Pohle T, Seidman DS, and Schroder H. Heme oxygenase-1 induction may explain the antioxidant profile of aspirin. Biochem Biophys Res Commun 308: 956-960, 2003.
59. Haloui M, Meilhac O, Jandrot-Perrus M, and Michel JB. Atorvastatin limits the pro-inflammatory response of rat aortic smooth muscle cells to thrombin. Eur J Pharmacol 474: 175-184, 2003.
60. Hayashi S, Takamiya R, Yamaguchi T, Matsumoto K, Tojo SJ, Tamatani T, Kitajima M, Makino N, Ishimura Y, and Suematsu M. Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme. Circ Res 85: 663-671, 1999.
61. Higashimoto Y, Sugishima M, Sato H, Sakamoto H, Fukuyama K, Palmer G, and Noguchi M. Mass spectro-metric identification of lysine residues of heme oxygenase-1 that are involved in its interaction with NADPH-cyto-chrome P450 reductase. Biochem Biophys Res Commun 367: 852-858, 2008.
62. Hill M, Pereira V, Chauveau C, Zagani R, Remy S, Tesson L, Mazal D, Ubillos L, Brion R, Asghar K, Mashreghi MF, Kotsch K, Moffett J, Doebis C, Seifert M, Boczkowski J, Osinaga E, and Anegon I. Heme oxygenase-1 inhibits rat and human breast cancer cell proliferation: mutual cross inhibition with indoleamine 2, 3-dioxygenase. FASEB J 19: 1957-1968, 2005.
63. Hinkelmann U, Grosser N, Erdmann K, Schroder H, and Immenschuh S. Simvastatin-dependent up-regulation of heme oxygenase-1 via mRNA stabilization in human en-dothelial cells. Eur J Pharm Sci 41: 118-124, 2010.
64. Hirai K, Sasahira T, Ohmori H, Fujii K, and Kuniyasu H. Inhibition of heme oxygenase-1 by zinc protoporphyrin IX reduces tumor growth of LL/2 lung cancer in C57BL mice. Int J Cancer 120: 500-505, 2007.
65. Hori R, Kashiba M, Toma T, Yachie A, Goda N, Makino N, Soejima A, Nagasawa T, Nakabayashi K, and Suematsu M. Gene transfection of H25A mutant heme oxygenase-1 protects cells against hydroperoxide-induced cytotoxicity. J Biol Chem 277: 10712-10718, 2002.
66. Horsfall LJ, Nazareth I, and Petersen I. Cardiovascular events as a function of serum bilirubin levels in a large, statin-treated cohort. Circulation 126: 2556-2564, 2012.
67. Hu CM, Lin HH, Chiang MT, Chang PF, and Chau LY. Systemic expression of heme oxygenase-1 ameliorates type 1 diabetes in NOD mice. Diabetes 56: 1240-1247, 2007.
68. Huang SH, Chu CH, Yu JC, Chuang WC, Lin GJ, Chen PL, Chou FC, Chau LY, and Sytwu HK. Transgenic expression of haem oxygenase-1 in pancreatic beta cells protects non-obese mice used as a model of diabetes from autoimmune destruction and prolongs graft survival following islet transplantation. Diabetologia 53: 2389-2400, 2010.
69. Huber WJ, 3rd and Backes WL. Expression and characterization of full-length human heme oxygenase-1: the presence of intact membrane-binding region leads to increased binding affinity for NADPH cytochrome P450 reductase. Biochemistry 46: 12212-12219, 2007.
70. Hwang HW, Lee JR, Chou KY, Suen CS, Hwang MJ, Chen C, Shieh RC, and Chau LY. Oligomerization is crucial for the stability and function of heme oxygenase-1 in the en-doplasmic reticulum. J Biol Chem 284: 22672-22679, 2009.
71. Inoguchi T, Sasaki S, Kobayashi K, Takayanagi R, and Yamada T. Relationship between Gilbert syndrome and prevalence of vascular complications in patients with diabetes. JAMA 298: 1398-1400, 2007.
72. Ishikawa K, Sugawara D, Wang X, Suzuki K, Itabe H, Maruyama Y, and Lusis AJ. Heme oxygenase-1 inhibits atherosclerotic lesion formation in ldl-receptor knockout mice. Circ Res 88: 506-512, 2001.
73. Jiang F, Roberts SJ, Datla, Sr., and Dusting GJ. NO modulates NADPH oxidase function via heme oxygenase-1 in human endothelial cells. Hypertension 48: 950-957, 2006.
74. Jozkowicz A, Huk I, Nigisch A, Weigel G, Dietrich W, Motterlini R, and Dulak J. Heme oxygenase and angiogenic activity of endothelial cells: stimulation by carbon monoxide and inhibition by tin protoporphyrin-IX. Antioxid Redox Signal 5: 155-162, 2003.
75. Jozkowicz A, Was H, and Dulak J. Heme oxygenase-1 in tumors: is it a false friend? Antioxid Redox Signal 9: 2099-2117, 2007.
76. Juan SH, Lee TS, Tseng KW, Liou JY, Shyue SK, Wu KK, and Chau LY. Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation 104: 1519-1525, 2001.
77. Juhasz B, Varga B, Czompa A, Bak I, Lekli I, Gesztelyi R, Zsuga J, Kemeny-Beke A, Antal M, Szendrei L, and Tosaki A. Postischemic cardiac recovery in heme oxygenase-1 transgenic ischemic/reperfused mouse myocardium. J Cell Mol Med 15: 1973-1982, 2011.
78. Jung NH, Kim HP, Kim BR, Cha SH, Kim GA, Ha H, Na YE, and Cha YN. Evidence for heme oxygenase-1 association with caveolin-1 and-2 in mouse mesangial cells. IUBMB Life 55: 525-532, 2003.
79. Kaneda H, Ohno M, Taguchi J, Togo M, Hashimoto H, Ogasawara K, Aizawa T, Ishizaka N, and Nagai R. Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. Arterioscler Thromb Vasc Biol 22: 1680-1685, 2002.
80. Kapturczak MH, Wasserfall C, Brusko T, Campbell-Thompson M, Ellis TM, Atkinson MA, and Agarwal A. Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse. Am J Pathol 165: 1045-1053, 2004.
81. Kawai Y, Garduno L, Theodore M, Yang J, and Arinze IJ. Acetylation-deacetylation of the transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) regulates its transcriptional activity and nucleocytoplasmic localization. J Biol Chem 286: 7629-7640, 2011.
82. Kawamura K, Ishikawa K, Wada Y, Kimura S, Matsumoto H, Kohro T, Itabe H, Kodama T, and Maruyama Y. Bilir-ubin from heme oxygenase-1 attenuates vascular endothe-lial activation and dysfunction. Arterioscler Thromb Vasc Biol 25: 155-160, 2005.
83. Kim HP, Wang X, Galbiati F, Ryter SW, and Choi AM. Caveolae compartmentalization of heme oxygenase-1 in endothelial cells. FASEB J 18: 1080-1089, 2004.
84. Kim KM, Pae HO, Zheng M, Park R, Kim YM, and Chung HT. Carbon monoxide induces heme oxygenase-1 via activation of protein kinase R-like endoplasmic reticulum kinase and inhibits endothelial cell apoptosis triggered by endoplasmic reticulum stress. Circ Res 101: 919-927, 2007.
85. Kim W, Bennett EJ, Huttlin EL, Guo A, Li J, Possemato A, Sowa ME, Rad R, Rush J, Comb MJ, Harper JW, and Gygi SP. Systematic and quantitative assessment of the ubiqui-tin-modified proteome. Mol Cell 44: 325-340, 2011.
86. Kim YS, Zhuang H, Koehler RC, and Dore S. Distinct protective mechanisms of HO-1 and HO-2 against hydro-peroxide-induced cytotoxicity. Free Radic Biol Med 38: 85-92, 2005.
87. Kimm H, Yun JE, Jo J, and Jee SH. Low serum bilirubin level as an independent predictor of stroke incidence: a prospective study in Korean men and women. Stroke 40: 3422-3427, 2009.
88. Kitamuro T, Takahashi K, Ogawa K, Udono-Fujimori R, Takeda K, Furuyama K, Nakayama M, Sun J, Fujita H, Hida W, Hattori T, Shirato K, Igarashi K, and Shibahara S. Bach1 functions as a hypoxia-inducible repressor for the heme oxygenase-1 gene in human cells. J Biol Chem 278: 9125-9133, 2003.
89. Kronke G, Kadl A, Ikonomu E, Bluml S, Furnkranz A, Sarembock IJ, Bochkov VN, Exner M, Binder BR, and Lei-tinger N. Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors. Arterioscler Thromb Vasc Biol 27: 1276-1282, 2007.
90. Lau AK, Leichtweis SB, Hume P, Mashima R, Hou JY, Chaufour X, Wilkinson B, Hunt NH, Celermajer DS, and Stocker R. Probucol promotes functional reendothelializa-tion in balloon-injured rabbit aortas. Circulation 107: 2031-2036, 2003.
91. Lee BS, Heo J, Kim YM, Shim SM, Pae HO, Kim YM, and Chung HT. Carbon monoxide mediates heme oxygenase 1 induction via Nrf2 activation in hepatoma cells. Biochem Biophys Res Commun 343: 965-972, 2006.
92. Lee PJ, Jiang BH, Chin BY, Iyer NV, Alam J, Semenza GL, and Choi AM. Hypoxia-inducible factor-1 mediates tran-scriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem 272: 5375-5381, 1997.
93. Lee TS, Chang CC, Zhu Y, and Shyy JY. Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection. Circulation 110: 1296-1302, 2004.
94. Lee TS and Chau LY. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 8: 240-246, 2002.
95. Lerner-Marmarosh N, Miralem T, Gibbs PE, and Maines MD. Human biliverdin reductase is an ERK activator; hBVR is an ERK nuclear transporter and is required for MAPK signaling. Proc Natl Acad Sci USA 105: 6870-6875, 2008.
96. Li Z, Wang Y, and Vanhoutte PM. Upregulation of heme oxygenase 1 by hemin impairs endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Hypertension 58: 926-934, 2011.
97. Li Volti G, Ientile R, Abraham NG, Vanella A, Cannavo G, Mazza F, Curro M, Raciti G, Avola R, and Campisi A. Immunocytochemical localization and expression of heme oxygenase-1 in primary astroglial cell cultures during differentiation: effect of glutamate. Biochem Biophys Res Com-mun 315: 517-524, 2004.
98. Lin CW, Shen SC, Hou WC, Yang LY, and Chen YC. Heme oxygenase-1 inhibits breast cancer invasion via suppressing the expression of matrix metalloproteinase-9. Mol Cancer Ther 7: 1195-1206, 2008.
99. Lin HH, Chen YH, Chang PF, Lee YT, Yet SF, and Chau LY. Heme oxygenase-1 promotes neovascularization in ische-mic heart by coinduction of VEGF and SDF-1. J Mol Cell Cardiol 45: 44-55, 2008.
100. Lin PH, Lan WM, and Chau LY. TRC8 suppresses tumor-igenesis through targeting heme oxygenase-1 for ubiquiti-nation and degradation. Oncogene 32: 2325-2334, 2012.
101. Lin Q, Weis S, Yang G, Weng YH, Helston R, Rish K, Smith A, Bordner J, Polte T, Gaunitz F, and Dennery PA. Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress. J Biol Chem 282: 20621-20633, 2007.
102. Lin QS, Weis S, Yang G, Zhuang T, Abate A, and Dennery PA. Catalytic inactive heme oxygenase-1 protein regulates its own expression in oxidative stress. Free Radic Biol Med 44: 847-855, 2008.
103. Linnenbaum M, Busker M, Kraehling JR, and Behrends S. Heme oxygenase isoforms differ in their subcellular trafficking during hypoxia and are differentially modulated by cytochrome P450 reductase. PLoS One 7: e35483, 2012.
104. Liu X, Wei J, Peng DH, Layne MD, and Yet SF. Absence of heme oxygenase-1 exacerbates myocardial ischemia/reperfusion injury in diabetic mice. Diabetes 54: 778-784, 2005.
105. Loboda A, Jazwa A, Jozkowicz A, Dorosz J, Balla J, Molema G, and Dulak J. Atorvastatin prevents hypoxia-induced inhibition of endothelial nitric oxide synthase expression but does not affect heme oxygenase-1 in human micro-vascular endothelial cells. Atherosclerosis 187: 26-30, 2006.
106. Loboda A, Stachurska A, Florczyk U, Rudnicka D, Jazwa A, Wegrzyn J, Kozakowska M, Stalinska K, Poellinger L, Levonen AL, Yla-Herttuala S, Jozkowicz A, and Dulak J. HIF-1 induction attenuates Nrf2-dependent IL-8 expression in human endo-thelial cells. Antioxid Redox Signal 11: 1501-1517, 2009.
107. Lynes EM, Bui M, Yap MC, Benson MD, Schneider B, Ell-gaard L, Berthiaume LG, and Simmen T. Palmitoylated TMX and calnexin target to the mitochondria-associated membrane. EMBO J 31: 457-470, 2012.
108. Machado RF, Reda D, Tropea M, Gladwin MT, and Suffredini AF. The effects of inhaled carbon monoxide on endotoxin-induced pulmonary inflammation in humans. Am J Respir Crit Care Med 179: A5673, 2009.
109. Maghzal GJ, Leck MC, Collinson E, Li C, and Stocker R. Limited role for the bilirubin-biliverdin redox amplification cycle in the cellular antioxidant protection by biliverdin reductase. J Biol Chem 284: 29251-29259, 2009.
110. Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37: 517-554, 1997.
111. Makabe S, Takahashi Y, Watanabe H, Murakami M, Ohba T, and Ito H. Fluvastatin protects vascular smooth muscle cells against oxidative stress through the Nrf2-dependent antioxidant pathway. Atherosclerosis 213: 377-384, 2010.
112. Marohnic CC, Huber Iii WJ, Patrick Connick J, Reed JR, McCammon K, Panda SP, Martasek P, Backes WL, and Masters BS. Mutations of human cytochrome P450 reduc-tase differentially modulate heme oxygenase-1 activity and oligomerization. Arch Biochem Biophys 513: 42-50, 2011.
113. McDonagh AF. The biliverdin-bilirubin antioxidant cycle of cellular protection: missing a wheel? Free Radic Biol Med 49: 814-820, 2010.
114. Midwinter RG, Maghzal GJ, Dennis JM, Wu BJ, Cai H, Kapralov AA, Belikova NA, Tyurina YY, Dong LF, Kha-chigian L, Neuzil J, Kagan VE, and Stocker R. Succinobucol induces apoptosis in vascular smooth muscle cells. Free Radic Biol Med 52: 871-879, 2012.
115. Minamino T, Christou H, Hsieh CM, Liu Y, Dhawan V, Abraham NG, Perrella MA, Mitsialis SA, and Kour-embanas S. Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc Natl Acad Sci USA 98: 8798-8803, 2001.
116. Moraes JA, Barcellos-de-Souza P, Rodrigues G, Nascimento-Silva V, Silva SV, Assreuy J, Arruda MA, and Barja-Fidalgo C. Heme modulates smooth muscle cell proliferation and migration via NADPH oxidase: a counter-regulatory role for heme oxygenase system. Atherosclerosis 224: 394-400, 2012.
117. Morikawa T, Kajimura M, Nakamura T, Hishiki T, Nakanishi T, Yukutake Y, Nagahata Y, Ishikawa M, Hattori K, Takenouchi T, Takahashi T, Ishii I, Matsubara K, Kabe Y, Uchiyama S, Nagata E, Gadalla MM, Snyder SH, and Suematsu M. Hypoxic regulation of the cerebral microcir-culation is mediated by a carbon monoxide-sensitive hydrogen sulfide pathway. Proc Natl Acad Sci USA 109: 1293-1298, 2012.
118. Nakao A, Neto JS, Kanno S, Stolz DB, Kimizuka K, Liu F, Bach FH, Billiar TR, Choi AM, Otterbein LE, and Murase N. Protection against ischemia/reperfusion injury in cardiac and renal transplantation with carbon monoxide, biliverdin and both. Am J Transplant 5: 282-291, 2005.
119. Nakayama M, Takahashi K, Kitamuro T, Yasumoto K, Katayose D, Shirato K, Fujii-Kuriyama Y, and Shibahara S. Repression of heme oxygenase-1 by hypoxia in vascular endothelial cells. Biochem Biophys Res Commun 271: 665-671, 2000.
120. Ndisang JF and Jadhav A. Heme oxygenase system enhances insulin sensitivity and glucose metabolism in streptozotocin-induced diabetes. Am J Physiol Endocrinol Metab 296: E829-E841, 2009.
121. Ndisang JF and Jadhav A. Up-regulating the hemeox-ygenase system enhances insulin sensitivity and improves glucose metabolism in insulin-resistant diabetes in Goto-Kakizaki rats. Endocrinology 150: 2627-2636, 2009.
122. Ndisang JF, Lane N, and Jadhav A. The heme oxygenase system abates hyperglycemia in Zucker diabetic fatty rats by potentiating insulin-sensitizing pathways. Endocrinology 150: 2098-2108, 2009.
123. Nicolai A, Li M, Kim DH, Peterson SJ, Vanella L, Positano V, Gastaldelli A, Rezzani R, Rodella LF, Drummond G, Kusmic C, L'Abbate A, Kappas A, and Abraham NG. Heme oxygenase-1 induction remodels adipose tissue and improves insulin sensitivity in obesity-induced diabetic rats. Hypertension 53: 508-515, 2009.
124. Orozco LD, Kapturczak MH, Barajas B, Wang X, Weinstein MM, Wong J, Deshane J, Bolisetty S, Shaposhnik Z, Shih DM, Agarwal A, Lusis AJ, and Araujo JA. Heme oxyge-nase-1 expression in macrophages plays a beneficial role in atherosclerosis. Circ Res 100: 1703-1711, 2007.
125. Otterbein LE, Bach FH, Alam J, Soares M, Tao Lu H, Wysk M, Davis RJ, Flavell RA, and Choi AM. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6: 422-428, 2000.
126. Otterbein LE, Hedblom A, Harris C, Csizmadia E, Gallo D, and Wegiel B. Heme oxygenase-1 and carbon monoxide modulate DNA repair through ataxia-telangiectasia mutated (ATM) protein. Proc Natl Acad Sci USA 108: 14491-14496, 2011.
127. Panchenko MV, Farber HW, and Korn JH. Induction of heme oxygenase-1 by hypoxia and free radicals in human dermal fibroblasts. Am J Physiol Cell Physiol 278: C92-C101, 2000.
128. Peyton KJ, Shebib AR, Azam MA, Liu XM, Tulis DA, and Durante W. Bilirubin inhibits neointima formation and vascular smooth muscle cell proliferation and migration. Front Pharmacol 3: 48, 2012.
129. Ponka P. Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. Blood 89: 1-25, 1997.
130. Poss KD and Tonegawa S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci USA 94: 10919-10924, 1997.
131. Qiu C, Hevner K, Enquobahrie DA, and Williams MA. Maternal serum heme-oxygenase-1 (HO-1) concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus. PLoS One 7: e48060, 2012.
132. Quan S, Kaminski PM, Yang L, Morita T, Inaba M, Ikehara S, Goodman AI, Wolin MS, and Abraham NG. Heme oxygenase-1 prevents superoxide anion-associated endo-thelial cell sloughing in diabetic rats. Biochem Biophys Res Commun 315: 509-516, 2004.
133. Radhakrishnan N, Yadav SP, Sachdeva A, Pruthi PK, Sawhney S, Piplani T, Wada T, and Yachie A. Human heme oxygenase-1 deficiency presenting with hemolysis, nephritis, and asplenia. J Pediatr Hematol Oncol 33: 74-78, 2011.
134. RadhakrishnanN, Yadav SP, SachdevaA, WadaT, and Yachie A. An interesting tetrad of asplenia, inflammation, hemolysis, and nephritis. Pediatr Hematol Oncol 28: 723-726, 2011.
135. Ryter SW, Alam J, and Choi AM. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 86: 583-650, 2006.
136. Sacca P, Meiss R, Casas G, Mazza O, Calvo JC, Navone N, and Vazquez E. Nuclear translocation of haeme oxygenase-1 is associated to prostate cancer. Br J Cancer 97: 1683-1689, 2007.
137. Salinas M, Wang J, Rosa de Sagarra M, Martin D, Rojo AI, Martin-Perez J, Ortiz de Montellano PR, and Cuadrado A. Protein kinase Akt/PKB phosphorylates heme oxygenase-1 in vitro and in vivo. FEBS Lett 578: 90-94, 2004.
138. Santiago FS, Lowe HC, Bobryshev YV, and Khachigian LM. Induction of the transcriptional repressor Yin Yang-1 by vascular cell injury. Autocrine/paracrine role of endogenous fibroblast growth factor-2. J Biol Chem 276: 41143-41149, 2001.
139. Sato K, Balla J, Otterbein L, Smith RN, Brouard S, Lin Y, Csizmadia E, Sevigny J, Robson SC, Vercellotti G, Choi AM, Bach FH, and Soares MP. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol 166: 4185-4194, 2001.
140. Sawayama Y, Shimizu C, Maeda N, Tatsukawa M, Kinu-kawa N, Koyanagi S, Kashiwagi S, and Hayashi J. Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia. Fukuoka Atherosclerosis Trial (FAST). J Am Coll Cardiol 39: 610-616, 2002.
141. Schillinger M, Exner M, Mlekusch W, Ahmadi R, Rumpold H, Mannhalter C,
142. Schroder K, Zhang M, Benkhoff S, Mieth A, Pliquett R, Kosowski J, Kruse C, Luedike P, Michaelis UR, Weissmann N, Dimmeler S, Shah AM, and Brandes RP. Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circ Res 110: 1217-1225, 2012.
143. Schuller DJ, Wilks A, Ortiz de Montellano P, and Poulos TL. Crystallization of recombinant human heme oxyge-nase-1. Protein Sci 7: 1836-1838, 1998.
144. Schuller DJ, Wilks A, Ortiz de Montellano PR, and Poulos TL. Crystal structure of human heme oxygenase-1. Nat Struct Biol 6: 860-867, 1999.
145. Schwertner HA, Jackson WG, and Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem 40: 18-23, 1994.
146. Shibahara S, Muller R, Taguchi H, and Yoshida T. Cloning and expression of cDNA for rat heme oxygenase. Proc Natl Acad Sci USA 82: 7865-7869, 1985.
147. Slebos DJ, Ryter SW, van der Toorn M, Liu F, Guo F, Baty CJ, Karlsson JM, Watkins SC, Kim HP, Wang X, Lee JS, Postma DS, Kauffman HF, and Choi AM. Mitochondrial localization and function of heme oxygenase-1 in cigarette smoke-induced cell death. Am J Respir Cell Mol Biol 36: 409-417, 2007.
148. Soares MP, Lin Y, Anrather J, Csizmadia E, Takigami K, Sato K, Grey ST, Colvin RB, Choi AM, Poss KD, and Bach FH. Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med 4: 1073-1077, 1998.
149. Solari V, Piotrowska AP, and Puri P. Expression of heme oxygenase-1 and endothelial nitric oxide synthase in the lung of newborns with congenital diaphragmatic hernia and persistent pulmonary hypertension. J Pediatr Surg 38: 808-813, 2003.
150. Song F, Li X, Zhang M, Yao P, Yang N, Sun X, Hu FB, and Liu L. Association between heme oxygenase-1 gene promoter polymorphisms and type 2 diabetes in a Chinese population. Am J Epidemiol 170: 747-756, 2009.
151. Song R, Kubo M, Morse D, Zhou Z, Zhang X, Dauber JH, Fabisiak J, Alber SM, Watkins SC, Zuckerbraun BS, Otter-bein LE, Ning W, Oury TD, Lee PJ, McCurry KR, and Choi AM. Carbon monoxide induces cytoprotection in rat or-thotopic lung transplantation via anti-inflammatory and anti-apoptotic effects. Am J Pathol 163: 231-242, 2003.
152. Srivastava P and Pandey VC. Mitochondrial heme oxygenase of Mastomys coucha. Int J Biochem Cell Biol 28: 1071-1077, 1996.
153. Stocker R. Molecular mechanisms underlying the anti-atherosclerotic and antidiabetic effects of probucol, succi-nobucol, and other probucol analogues. Curr Opin Lipidol 20: 227-235, 2009.
154. Stocker R, McDonagh AF, Glazer AN, and Ames BN. An-tioxidant activities of bile pigments: biliverdin and biliru-bin. Methods Enzymol 186: 301-309, 1990.
155. Stocker R and Perrella MA. Heme oxygenase-1: a novel drug target for atherosclerotic diseases? Circulation 114: 2178-2189, 2006.
156. Sun Y, Rotenberg MO, and Maines MD. Developmental expression of heme oxygenase isozymes in rat brain. Two HO-2 mRNAs are detected. J Biol Chem 265: 8212-8217, 1990.
157. Suzuki M, Iso-o N, Takeshita S, Tsukamoto K, Mori I, Sato T, Ohno M, Nagai R, and Ishizaka N. Facilitated angio-genesis induced by heme oxygenase-1 gene transfer in a rat model of hindlimb ischemia. Biochem Biophys Res Commun 302: 138-143, 2003.
158. Taha H, Skrzypek K, Guevara I, Nigisch A, Mustafa S, Grochot-Przeczek A, Ferdek P, Was H, Kotlinowski J, Kozakowska M, Balcerczyk A, Muchova L, Vitek L, Weigel G, Dulak J, and Jozkowicz A. Role of heme oxy-genase-1 in human endothelial cells: lesson from the promoter allelic variants. Arterioscler Thromb Vasc Biol 30: 1634-1641, 2010.
159. Taira J, Sugishima M, Kida Y, Oda E, Noguchi M, and Higashimoto Y. Caveolin-1 is a competitive inhibitor of heme oxygenase-1 (HO-1) with heme: identification of a minimum sequence in caveolin-1 for binding to HO-1. Biochemistry 50: 6824-6831, 2011.
160. Tanous D, Brasen JH, Choy K, Wu BJ, Kathir K, Lau A, Celermajer DS, and Stocker R. Probucol inhibits in-stent thrombosis and neointimal hyperplasia by promoting re-endothelialization. Atherosclerosis 189: 342-349, 2006.
161. Tardif JC, Gregoire J, Schwartz L, Title L, Laramee L, Reeves F, Lesperance J, Bourassa MG, L'Allier PL, Glass M, Lambert J, and Guertin MC. Effects of AGI-1067 and pro-bucol after percutaneous coronary interventions. Circulation 107: 552-558, 2003.
162. Tardif JC, McMurray JJ, Klug E, Small R, Schumi J, Choi J, Cooper J, Scott R, Lewis EF, L'Allier PL, and Pfeffer MA. Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial. Lancet 371: 1761-1768, 2008.
163. Tenhunen R, Marver HS, and Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxy-genase. Proc Natl Acad Sci USA 61: 748-755, 1968.
164. Tenhunen RMH and Schmid R. Microsomal heme oxyge-nase. Characterization of the enzyme. J Biol Chem 244: 6388-6394, 1969.
165. Thompson KJ, Fried MG, Ye Z, Boyer P, and Connor JR. Regulation, mechanisms and proposed function of ferritin translocation to cell nuclei. J Cell Sci 115: 2165-2177, 2002.
166. Tiroch K, Koch W, von Beckerath N, Kastrati A, and Schomig A. Heme oxygenase-1 gene promoter polymorphism and restenosis following coronary stenting. Eur Heart J 28: 968-973, 2007.
167. Tongers J, Knapp JM, Korf M, Kempf T, Limbourg A, Limbourg FP, Li Z, Fraccarollo D, Bauersachs J, Han X, Drexler H, Fiedler B, and Wollert KC. Haeme oxygenase promotes progenitor cell mobilization, neovascularization, and functional recovery after critical hindlimb ischaemia in mice. Cardiovasc Res 78: 294-300, 2008.
168. Torpey J and Ortiz de Montellano PR. Oxidation of the meso-methylmesoheme regioisomers by heme oxygenase. Electronic control of the reaction regiospecificity. J Biol Chem 271: 26067-26073, 1996.
169. Tulis DA, Durante W, Liu X, Evans AJ, Peyton KJ, and Schafer AI. Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation. Circulation 104: 2710-2715, 2001.
170. Tulis DA, Durante W, Peyton KJ, Evans AJ, and Schafer AI. Heme oxygenase-1 attenuates vascular remodeling following balloon injury in rat carotid arteries. Atherosclerosis 155: 113-122, 2001.
171. Tulis DA, Keswani AN, Peyton KJ, Wang H, Schafer AI, and Durante W. Local administration of carbon monoxide inhibits neointima formation in balloon injured rat carotid arteries. Cell Mol Biol (Noisy-le-grand) 51: 441-446, 2005.
172. Turkseven S, Drummond G, Rezzani R, Rodella L, Quan S, Ikehara S, and Abraham NG. Impact of silencing HO-2 on EC-SOD and the mitochondrial signaling pathway. J Cell Biochem 100: 815-823, 2007.
173. Uchiyama T, Atsuta H, Utsugi T, Ohyama Y, Nakamura T, Nakai A, Nakata M, Maruyama I, Tomura H, Okajima F, Tomono S, Kawazu S, Nagai R, and Kurarbayashi M. Simvastatin induces heat shock factor 1 in vascular endo-thelial cells. Atherosclerosis 188: 265-273, 2006.
174. Vanella L, Li M, Kim D, Malfa G, Bellner L, Kawakami T, and Abraham NG. ApoA1: mimetic peptide reverses adi-pocyte dysfunction in vivo and in vitro via an increase in heme oxygenase (HO-1) and Wnt10b. Cell Cycle 11: 706-714, 2012.
175. Walldius G, Erikson U, Olsson AG, Bergstrand L, Hadell K, Johansson J, Kaijser L, Lassvik C, Molgaard J, Nilsson S, et al. The effect of probucol on femoral atherosclerosis: the Probucol Quantitative Regression Swedish Trial (PQRST). Am J Cardiol 74: 875-883, 1994.
176. Wang B, Cao W, Biswal S, and Dore S. Carbon monoxide-activated Nrf2 pathway leads to protection against permanent focal cerebral ischemia. Stroke 42: 2605-2610, 2011.
177. Wang J, Lad L, Poulos TL, and Ortiz de Montellano PR. Re-giospecificity determinants of human heme oxygenase: differential NADPH-and ascorbate-dependent heme cleavage by the R183E mutant. J Biol Chem 280: 2797-2806, 2005.
178. Wang LJ, Lee TS, Lee FY, Pai RC, and Chau LY. Expression of heme oxygenase-1 in atherosclerotic lesions. Am J Pathol 152: 711-720, 1998.
179. Wang XM, Kim HP, Nakahira K, Ryter SW, and Choi AM. The heme oxygenase-1/carbon monoxide pathway suppresses TLR4 signaling by regulating the interaction of TLR4 with caveolin-1. J Immunol 182: 3809-3818, 2009.
180. Was H, Dulak J, and Jozkowicz A. Heme oxygenase-1 in tumor biology and therapy. Curr Drug Targets 11: 1551-1570, 2010.
181. Wilks A, Medzihradszky KF, and Ortiz de Montellano PR. Heme oxygenase active-site residues identified by heme-protein cross-linking during reduction of CBrCl3. Biochemistry 37: 2889-2896, 1998.
182. Wilks A and Ortiz de Montellano PR. Rat liver heme oxy-genase. High level expression of a truncated soluble form and nature of the meso-hydroxylating species. J Biol Chem 268: 22357-22362, 1993.
183. Williams SE, Wootton P, Mason HS, Bould J, Iles DE, Ric-cardi D, Peers C, and Kemp PJ. Hemoxygenase-2 is an oxygen sensor for a calcium-sensitive potassium channel. Science 306: 2093-2097, 2004.
184. Wu BJ, Chen K, Barter PJ, and Rye KA. Niacin inhibits vascular inflammation via the induction of heme oxyge-nase-1. Circulation 125: 150-158, 2012.
185. Wu BJ, Chen K, Shrestha S, Ong KL, Barter PJ, and Rye KA. High density lipoproteins inhibit vascular endothelial inflammation by increasing 3b-hydroxysteroid-D24 reductase expression and inducing heme oxygenase-1. Circ Res 112: 278-288, 2013.
186. Wu BJ, Kathir K, Witting PK, Beck K, Choy K, Li C, Croft KD, Mori TA, Tanous D, Adams MR, Lau AK, and Stocker R. Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging. J Exp Med 203: 1117-1127, 2006.
187. Wu BJ, Midwinter RG, Cassano C, Beck K, Wang Y, Changsiri D, Gamble JR, and Stocker R. Heme oxygenase-1 increases endothelial progenitor cells. Arterioscler Thromb Vasc Biol 29: 1537-1542, 2009.
188. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, Ohta K, Kasahara Y, and Koizumi S. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 103: 129-135, 1999.
189. Yamamoto N, Izumi Y, Matsuo T, Wakita S, Kume T, Taka-da-Takatori Y, Sawada H, and Akaike A. Elevation of heme oxygenase-1 by proteasome inhibition affords dopaminergic neuroprotection. J Neurosci Res 88: 1934-1942, 2010.
190. Yamashita S, Hbujo H, Arai H, Harada-Shiba M, Matsui S, Fukushima M, Saito Y, Kita T, and Matsuzawa Y. Long-term probucol treatment prevents secondary cardiovascular events: a cohort study of patients with heterozygous familial hypercholesterolemia in Japan. J Atheroscler Thromb 15: 292-303, 2008.
191. Yet SF, Layne MD, Liu X, Chen YH, Ith B, Sibinga NE, and Perrella MA. Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling. FASEB J 17: 1759-1761, 2003.
192. Yet SF, Perrella MA, Layne MD, Hsieh CM, Maemura K, Kobzik L, Wiesel P, Christou H, Kourembanas S, and Lee ME. Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J Clin Invest 103: R23-R29, 1999.
193. Yi L and Ragsdale SW. Evidence that the heme regulatory motifs in heme oxygenase-2 serve as a thiol/disulfide redox switch regulating heme binding. J Biol Chem 282: 21056-21067, 2007.
194. Yoshida T, Ishikawa K, and Sato M. Degradation of heme by a soluble peptide of heme oxygenase obtained from rat liver microsomes by mild trypsinization. Eur J Biochem 199: 729-733, 1991.
195. Yoshida T and Kikuchi G. Features of the reaction of heme degradation catalyzed by the reconstituted microsomal heme oxygenase system. J Biol Chem 253: 4230-4236, 1978.
196. Yoshida T and Kikuchi G. Purification and properties of heme oxygenase from pig spleen microsomes. J Biol Chem 253: 4224-4229, 1978.
197. Yoshida T, Maulik N, Ho YS, Alam J, and Das DK. H(mox-1) constitutes an adaptive response to effect antioxidant cardioprotection: a study with transgenic mice heterozygous for targeted disruption of the Heme oxygenase-1 gene. Circulation 103: 1695-1701, 2001.
198. Zhao H, Azuma J, Kalish F, Wong RJ, and Stevenson DK. Maternal heme oxygenase 1 regulates placental vasculature development via angiogenic factors in mice. Biol Reprod 85: 1005-1012, 2011.
199. Zhao S, Xu W, Jiang W, Yu W, Lin Y, Zhang T, Yao J, Zhou L, Zeng Y, Li H, Li Y, Shi J, An W, Hancock SM, He F, Qin L, Chin J, Yang P, Chen X, Lei Q, Xiong Y, and Guan KL. Regulation of cellular metabolism by protein lysine acety-lation. Science 327: 1000-1004, 2010.
200. Zhu C, Xiong Z, Zheng Z, Chen Y, Chen X, and Qian X. Association of arterial stiffness with serum bilirubin levels in established coronary artery disease. Intern Med 51: 2083-2089, 2012.